Position in IBRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,422,585
New position
Shares Held
185,474
first reported quarter
Ownership
0.018%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026FORA Capital, LLC holds $20,857,761 across 23 Biotechnology names. IBRX ranks #9 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
23,625 | $1,481,287 | |
| 2 | KRYS |
Krystal Biotech, Inc.
|
5,732 | $1,480,690 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
15,218 | $1,479,950 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
53,409 | $1,479,429 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,471 | $1,479,319 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
19,693 | $1,478,747 | |
| 7 | ABVX |
Abivax S.A.
|
13,186 | $1,468,261 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
27,120 | $1,429,766 |
All Filings in IBRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,422,585 | 185,474 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||